Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma

Volume: 35, Issue: 5, Pages: 279 - 285
Published: May 1, 2017
Abstract
This study aimed to determine the serum levels of angiopoietin-like 4 (ANGPTL4) in patients with renal cell carcinoma (RCC) and explore its potential as a biomarker. Blood samples were taken from 110 patients with RCC, 66 healthy controls, and patients with other solid tumors. Serum ANGPTL4 levels were measured using the enzyme-linked immunosorbent assay, and their correlation with clinical characteristics was further analyzed. Received...
Paper Details
Title
Serum level of ANGPTL4 as a potential biomarker in renal cell carcinoma
Published Date
May 1, 2017
Volume
35
Issue
5
Pages
279 - 285
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.